Medicinos mokslų centras - Company finances
|
EUR
|
2024
From: 2024-01-08
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|
|
Financial data
|
||
| Sales revenue | 266,850 | 198,977 |
| Profit before tax | 245,848 | 165,340 |
| Net profit | 245,848 | 155,724 |
| Equity | 247,848 | 403,572 |
| Liabilities | 6,704 | 237,916 |
| Non-current assets | 0 | 243,738 |
| Current assets | 254,552 | 397,750 |
| Total assets | 254,552 | 641,488 |
|
Taxes paid
|
||
| STI taxes | 37,191 | 10,614 |
|
Financial indicators
|
||
| Revenue change y/y | - | -25.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 96.6% | 24.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 99.2% | 38.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 92.1% | 78.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 92.1% | 83.1% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.0 | 0.6 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 266,850 | 198,977 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Medicinos mokslų centras - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-09-01 | 2026-09-02 | 80.48 |
| 2026-08-01 | 2026-08-03 | 80.48 |
| 2026-07-01 | 2026-07-02 | 80.48 |
| 2026-06-02 | 2026-06-07 | 80.48 |
| 2026-05-03 | 2026-05-06 | 80.48 |
| 2026-04-01 | 2026-04-08 | 80.48 |
| 2026-01-01 | 2026-01-05 | 72.45 |
| 2025-12-02 | 2025-12-03 | 72.45 |
| 2025-11-01 | 2025-11-04 | 72.45 |
| 2025-10-01 | 2025-10-01 | 72.45 |
| 2025-09-02 | 2025-09-02 | 72.45 |
| 2025-08-01 | 2025-08-05 | 72.45 |
| 2025-07-01 | 2025-07-01 | 72.45 |
| 2025-06-03 | 2025-06-03 | 72.45 |
| 2025-05-04 | 2025-05-04 | 72.45 |
| 2025-04-01 | 2025-04-02 | 72.45 |
| 2025-03-18 | 2025-03-18 | 43.69 |
| 2025-03-03 | 2025-03-03 | 43.69 |
| 2025-03-01 | 2025-03-02 | 116.14 |
| 2025-02-18 | 2025-02-28 | 43.69 |
| 2025-02-01 | 2025-02-04 | 43.69 |
| 2025-01-02 | 2025-01-06 | 108.19 |
| 2024-12-22 | 2024-12-31 | 43.69 |
| 2024-12-17 | 2024-12-20 | 43.69 |
| 2024-11-18 | 2024-12-02 | 43.69 |
| 2024-11-04 | 2024-11-06 | 43.69 |
Medicinos mokslų centras - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-03-28 | 2025-04-25 | 1.0 |
| 2025-02-28 | 2025-03-24 | 1.0 |
| 2025-01-30 | 2025-02-25 | 1.0 |
| 2024-12-30 | 2025-01-24 | 1.0 |
| 2024-11-28 | 2024-12-27 | 1.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Medicinos mokslu centras, MB (code 306656644) is a Lithuanian small partnership engaged in research and development in medical sciences. In 2025, the company generated revenue of €199.0K, down 25.4% year on year from €266.9K in 2024. Despite the decline in turnover, profitability remained strong: net profit was €155.7K in 2025, compared with €245.8K in 2024, and the net margin stayed very high at 78.3%. The 2024 financial year showed an even stronger margin of 92.1%, reflecting a highly profitable business model, although on a smaller revenue base.
The balance sheet expanded significantly in 2025. Total assets increased to €641.5K from €254.6K a year earlier, while equity rose to €403.6K from €247.8K. Liabilities also grew to €237.9K from €6.7K, yet the equity ratio remained solid at 62.9% and debt-to-equity stood at 0.59. Return on equity was 38.6% and return on assets 24.3%, indicating efficient use of capital. Asset turnover was 0.31x. Revenue per employee was €199.0K, and profit per employee was €155.7K.
The balance sheet expanded significantly in 2025. Total assets increased to €641.5K from €254.6K a year earlier, while equity rose to €403.6K from €247.8K. Liabilities also grew to €237.9K from €6.7K, yet the equity ratio remained solid at 62.9% and debt-to-equity stood at 0.59. Return on equity was 38.6% and return on assets 24.3%, indicating efficient use of capital. Asset turnover was 0.31x. Revenue per employee was €199.0K, and profit per employee was €155.7K.